Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer

Showing 15 posts of 262 posts found.

Xarelto picture

NICE wants more information on Xarelto

March 13, 2012
Sales and Marketing Bayer, DVT, NICE, Xarelto

NICE is asking Bayer for more information about its blood thinner Xarelto in new guidance.  The watchdog is currently minded …

News
jlowinski

Former Bayer man becomes senior VP of Sanofi’s Asia region

March 5, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Asia, Bayer, Sanofi

Sanofi has appointed Jean-Luc Lowinski as its new senior vice president of the Asia region, effective from 1 May.  Jean-Luc …

Appointment
werner_wenning_bayer

Werner Wenning proposed as chairman of the supervisory board at Bayer

February 24, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Schneider, Wenning

Former Bayer chief executive Werner Wenning is set to be elected to the supervisory board at Bayer with effect from October. …

Appointment

Bayer eye drug succeeds in long-term study

February 21, 2012
Research and Development, Sales and Marketing Bayer, Lucentis, aflibercept, wet AMD

Bayer’s eye drug aflibercept has succeeded in a long-term study in patients with a common eye condition.  The Phase III …

News

Bayer UK/Ireland appoints new chief financial officer

February 9, 2012
Business Services, Sales and Marketing Bayer, Ute Bockstegers

Bayer has appointed Ms Ute Bockstegers as chief financial officer and head of business administration and partnering.Ute Bockstegers comes to …

Appointment
Bayer image

Bayer’s colorectal cancer drug increases survival

January 19, 2012
Research and Development, Sales and Marketing Bayer, colectoral cancer, regorafenib

Bayer and Onyx’s colorectal cancer drug regorafenib increased overall survival for late-stage patients, according to new data. The Phase III …

News
Eylea picture

Lucentis rival gains US approval

November 22, 2011
Research and Development, Sales and Marketing Bayer, Eylea, Lucentis, Novartis, Regeneron, Roche

A rival to Roche and Novartis’ drug Lucentis has received FDA approval for a common form of eye disease. Eylea …

News

Bayer forecasts €11 billion growth in Asia

November 17, 2011
Bayer, China, emerging markets

Bayer is expecting sales in Asia to grow by €11 billion over the next four years, with over half of …

News

Xarelto succeeds in new study

November 14, 2011
Sales and Marketing Bayer, FDA, J&J, JJ, Xarelto

In a new study J&J and Bayer’s blood thinner Xarelto reduced deaths in patients after a heart attack, which could …

News

Emerging markets help Bayer through tough quarter

October 28, 2011
Sales and Marketing Bayer, Xarelto, emerging markets

Bayer has posted modest results for the third quarter, with growth in emerging markets compensating for austerity measures in Europe …

News

Abbott spin-off could attract mega merger

October 21, 2011
Research and Development, Sales and Marketing Abbott, Bayer, Humira, Merck, Roche

Abbott’s new spin-off pharma firm could attract a lot of attention from big pharma looking to sure up their portfolios. …

News

Bayer planning joint venture to make drugs in Russia

October 12, 2011
Manufacturing and Production Bayer, pharma manufacturing news

Germany’s Bayer AG has joined a number of its peers in the pharmaceutical industry with the signing of an agreement …

News
Blog footer

Digital Pharma: Twitter slip-up shouldn’t silence pharma

September 9, 2011
Medical Communications, Sales and Marketing Bayer, Code of Practice, Digital Pharma blog, PMCPA, Twitter

Bayer UK was recently ruled to have breached the ABPI Code of Practice by promoting prescription-only medicines to the general …

News
Bayer

FDA fast tracks Bayer prostate cancer drug

August 23, 2011
Sales and Marketing Algeta, Alpharadin, Bayer, prostate cancer

Bayer’s potential blockbuster prostate cancer drug Alpharadin has been granted a fast track review by the FDA, meaning it could …

News
Blog footer

Digital Pharma: Bayer reprimanded over social media use

August 17, 2011
Medical Communications ABPI Code of Practice, Bayer, Digital Pharma blog, PMCPA

Bayer will be named in the medical press after being found guilty of the first social media breach of the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025